Kulkarni Samarth

CIK 00016820195 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001682019

Recent Transactions

50 trades

Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2024-12-24−13,751→ 0 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2024-12-24$16.21/sh+13,751→ 195,291 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2024-12-02$55.10/sh−15,000→ 181,540 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2024-11-11$56.27/sh−6,879→ 196,540 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2024-11-11$55.43/sh−23,121→ 203,419 total
Award
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2024-10-16+400,000→ 400,000 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2024-10-16+55,000→ 55,000 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2024-10-14$46.28/sh−4,293→ 226,540 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2024-10-13+8,333→ 230,833 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2024-10-13−8,333→ 16,667 total
Gift
CRISPR Therapeutics AG$CRSP
Common Shares
2024-08-08−100,000→ 222,500 total
Award
Centessa Pharmaceuticals plc$CNTA
Share Option (right to buy)
2024-06-25+48,000→ 48,000 total
Award
Repare Therapeutics Inc.$RPTX
Stock Option (right to buy)
2024-06-17+27,200→ 27,200 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Stock Option (Right to Buy)
2024-06-06+30,550→ 30,550 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2024-04-15$59.88/sh−18,378→ 209,326 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2024-04-15$19.12/sh+19,582→ 227,704 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2024-04-15$60.40/sh−1,204→ 208,122 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2024-04-15−19,582→ 0 total
Award
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2024-03-20+78,750→ 78,750 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2024-03-20+105,000→ 105,000 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2024-03-15$19.12/sh+20,000→ 228,122 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2024-03-15$71.97/sh−10,613→ 217,509 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2024-03-15−20,000→ 19,582 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2024-03-15$73.06/sh−9,387→ 208,122 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2024-03-12$74.44/sh−4,583→ 208,122 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2024-03-11−9,000→ 9,000 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2024-03-11$78.26/sh−9,802→ 203,705 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2024-03-11+9,000→ 212,705 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2024-03-10+19,250→ 213,507 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2024-03-10−19,250→ 57,750 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2024-02-20$79.67/sh−6,370→ 194,257 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2024-02-18+13,250→ 200,627 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2024-02-18−13,250→ 26,500 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2024-02-15−20,000→ 39,582 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2024-02-15$81.04/sh−5,951→ 188,477 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2024-02-15$81.66/sh−1,100→ 187,377 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2024-02-15$19.12/sh+20,000→ 207,377 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2024-02-15$79.94/sh−12,949→ 194,428 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2024-01-29$61.10/sh−700→ 187,377 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2024-01-29$60.50/sh−49,300→ 188,077 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2024-01-29−50,000→ 100,000 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2024-01-29$19.12/sh+50,000→ 237,377 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2024-01-16$19.12/sh+20,000→ 207,377 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2024-01-16−20,000→ 59,582 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2024-01-16$62.50/sh−20,000→ 187,377 total
Tax Payment
CRISPR Therapeutics AG$CRSP
Common Shares
2023-03-13$43.22/sh−5,358→ 382,463 total
Tax Payment
CRISPR Therapeutics AG$CRSP
Common Shares
2023-03-13$43.22/sh−4,086→ 387,377 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2023-03-11−9,000→ 18,000 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2023-03-11+9,000→ 391,463 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2023-03-10−11,833→ 0 total

Companies

Recent Filings

Address

C/O CRISPR THERAPEUTICS 105 WEST FIRST STREET

BOSTON, MA, 02127

View on SEC.gov